Rallybio (RLYB) Stock Price
Rallybio Price
For Rallybio, the net margin of -1,046.4% is up versus -9,084.1% a few years ago. The consensus 12-month price target for Rallybio is 7.65 USD, about 55.1% below where the stock trades today. Of 11 analysts, 10 rate the stock a buy — an overall Buy consensus.
Rallybio stock price
Rallybio business model & stock analysis
Frequently asked questions about Rallybio
Analysts currently set an average price target of 8.42 USD for the Rallybio stock (median: 7.65 USD), implying -50.6 % versus the latest price. The consensus is based on 11 analyst ratings.
6 analysts currently rate the Rallybio stock: 0 recommend buying, 3 holding and 3 selling.
Converted at the current exchange rate, the Rallybio share trades at 15.19 EUR (17.02 USD).
The Rallybio share (RLYB) is listed on 1 stock exchanges, including: NASDAQ (RLYB).
The revenue cannot currently be calculated for Rallybio.
The expected profit of Rallybio is -29.15 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Rallybio is currently -3.09. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Rallybio stock.
The P/S cannot be calculated for Rallybio currently.
The Eulerpool Quality Score for Rallybio is 3/10.
The ISIN of Rallybio is US75120L2097. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Rallybio is RLYB. The ticker symbol is used to trade Rallybio shares on the stock exchange.
Rallybio stock
Rallybio Peer Group
Rallybio Ticker
All fundamentals and in-depth analysis of Rallybio
Our stock analysis for Rallybio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rallybio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.